(Q56524160)

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis (English)

0 references

0 references

1 reference

Shunzeng Lv

1

0 references

Ekaterina Turlova

2

0 references

Shigang Zhao

3

0 references

Huihui Kang

4

0 references

Mingzhi Han

5

0 references

Hong-Shuo Sun

6

0 references

language of work or name

English

0 references

publication date

February 2014

0 references

published in

Tumor Biology

0 references

volume

35

0 references

issue

2

0 references

page(s)

1565-74

0 references

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Structural, functional and therapeutic biology of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin as a prognostic/predictive marker and molecular target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Targeting survivin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

The role of survivin as a new target of diagnosis and treatment in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Predicting survival after radical cystectomy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1216-Y

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

12 December 2020

Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.

1 reference

12 December 2020

Expression of COX-2, survivin in regional lymph node metastases of gastric carcinoma and the correlation with prognosis

1 reference

12 December 2020

Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining

1 reference

12 December 2020

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

1 reference

12 December 2020

Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis

1 reference

12 December 2020

Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas

1 reference

12 December 2020

Molecular markers in bladder cancer

1 reference

12 December 2020

The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma

1 reference

12 December 2020